| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/12/2009 | US20090070088 Method and Apparatus fo Computer Modeling Diabetes |
| 03/12/2009 | US20090069565 New indole derivatives as factor xa inhibitors |
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069383 Thrombin Receptor Antagonists |
| 03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069301 Acridine and Quinoline Derivatives as Sirtuin Modulators |
| 03/12/2009 | US20090069295 Deuterium-enriched conivaptan |
| 03/12/2009 | US20090069246 Methods for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090069223 Method for treatment of vascular hyperpermeability |
| 03/12/2009 | US20090068717 In vivo incorporation of unnatural amino acids |
| 03/12/2009 | US20090068246 Collagen-related peptides and uses thereof |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | DE102007043177A1 Use of a composition containing an ingredient e.g. hydrated silicic acid, sorbitol, glycerin, polyethylene glycol, sodium lauryl sulfate, sodium fluoride, titanium dioxide, xanthan and carrageen for the treatment of hematoma |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2697404A1 Method for purifying the factor viii and the von willebrand factor |
| 03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
| 03/11/2009 | EP2032567A1 Substituted heterocycles and use thereof |
| 03/11/2009 | EP2032560A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 03/11/2009 | EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb |
| 03/11/2009 | EP1524981B1 Sustained release formulations comprising lamotrigine |
| 03/11/2009 | EP1517919B1 Marked peptides having affinity for a phospholipid and uses |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1302476B1 Reduced fk228 and use thereof |
| 03/11/2009 | CN101384594A Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 03/11/2009 | CN101384590A Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 03/11/2009 | CN101384585A Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 03/11/2009 | CN101381412A Polymer/recombinant human erythropoietin couple |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101380461A Efficient thymosin enteric-coated tablets and thymosin for injection |
| 03/11/2009 | CN101380450A Traditional Chinese medicine composition for treating birds ascites syndrome |
| 03/11/2009 | CN101380441A Quality standard of traditional Chinese medicine preparation capable of regulating menstruation, enriching blood, warming uterus, driving cold and relieving pain and inspection method thereof |
| 03/11/2009 | CN101380439A Chinese herbal medicine feed additive for preventing and treating ascites syndrome in broilers and preparation method thereof |
| 03/11/2009 | CN101380356A Tibetan medicine Duyiwei total flavone extract and extraction method and use thereof |
| 03/11/2009 | CN101380343A Extraction from mixture of angelica and ligusticum wallichii rhizome and extraction method |
| 03/11/2009 | CN101380322A A new use for deferiprone |
| 03/11/2009 | CN101380294A Preparation method of solid dispersion medicine for treating hemorrhage |
| 03/11/2009 | CN101380098A Health products capable of promoting urination and dispelling edema and preparation method thereof |
| 03/11/2009 | CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 03/11/2009 | CN100467073C Implants with a phosphazene-containing coating |
| 03/11/2009 | CN100467026C Application of paeoniflorin in preparing blood enriching medicines |
| 03/11/2009 | CN100467022C Application of 21(S) argatroban |
| 03/10/2009 | US7501403 Bile acid or bile salt fatty acid conjugates |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/05/2009 | WO2009029682A1 Combination therapy with syk kinase inhibitor |
| 03/05/2009 | WO2009028707A1 Inhibitor of ischemic disorders |
| 03/05/2009 | WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same |
| 03/05/2009 | WO2009028573A1 Use of ribavirin in blood coagulation disorder |
| 03/05/2009 | WO2009028559A1 Water-absorbing polymer particle and method for producing water-absorbing polymer particle |
| 03/05/2009 | WO2009027844A2 Crf conjugates with extended half-lives |
| 03/05/2009 | WO2009027437A1 Liquid formulation of g-csf conjugate |
| 03/05/2009 | WO2009027076A1 Liquid formulation of g-csf |
| 03/05/2009 | WO2009027056A2 Antioxidant and paramagnetic heparin-nitroxide derivatives |
| 03/05/2009 | WO2009011889A3 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 03/05/2009 | WO2007126365A8 Further medical uses of antisecretory protein |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062271 Antithrombotic Diamides |
| 03/05/2009 | US20090062210 Methods for promoting erythropoiesis |
| 03/05/2009 | US20090060843 Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes |
| 03/05/2009 | CA2697900A1 Inhibitor of ischemic disorders |
| 03/05/2009 | CA2697376A1 Liquid formulation of g-csf |
| 03/05/2009 | CA2696594A1 Liquid formulation of g-csf conjugate |
| 03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 03/04/2009 | EP2030624A1 Antioxidant and paramagnetic heparin-nitroxide derivatives |
| 03/04/2009 | EP2029738A2 Factor ix analogues having prolonged in vivo half life |
| 03/04/2009 | EP2029590A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydro-imidazopyridine and tetrahydrotriazolopyridine derivatives and use thereof |
| 03/04/2009 | EP2029589A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
| 03/04/2009 | EP2029582A1 Isoindolin-1-one-, isoindolin-3-one- and isoindolin-1,3-dione-derivatives and use thereof |
| 03/04/2009 | EP2029546A1 Aryl-substituted heterocycles, and use thereof |
| 03/04/2009 | EP2029161A2 Use of non-catalytic form of heparanase and peptides thereof for reversing the anti-coagulant effects of heparinoids |
| 03/04/2009 | EP2029137A2 Antihypertensive therapy method |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1499736B1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
| 03/04/2009 | EP1181366B1 Mammalian receptor proteins; related reagents and methods |
| 03/04/2009 | CN101379084A Novel anticoagulant polypeptides and complex |
| 03/04/2009 | CN101378730A Granular material comprising water-insoluble inorganic phosphate binders |
| 03/04/2009 | CN101376882A Preparation technique and use of ricefield eel fibrin ferment |
| 03/04/2009 | CN101376875A Pichia yeast expressing recombinant human blood coagulation factor VII, and preparation and use thereof |
| 03/04/2009 | CN101376676A PEGylated erythropoietin protein long-acting preparation |
| 03/04/2009 | CN101376022A Medicament composition containing defibrase modified by PEG |
| 03/04/2009 | CN101376000A King powder haemostatic |
| 03/04/2009 | CN101375998A (Compound honeybee and bovine colostrum) haemostatic |
| 03/04/2009 | CN101375977A Chinese medicinal composition for preventing and treating hydrothorax and ascites symptoms of birds |
| 03/04/2009 | CN101375976A Moxa roll containing cattail pollen charcoal powder |
| 03/04/2009 | CN101375969A (Compound honeybee and bovine colostrums) hematinic |
| 03/04/2009 | CN101375940A Baicao Chinese medicinal composition for eliminating ascites and preparation method thereof |
| 03/04/2009 | CN101375909A Moxa roll containing carbon powder of erberry |
| 03/04/2009 | CN101375873A Moxa roll containing Crinis carbonisatus powder |
| 03/04/2009 | CN101375859A Compound composite medicament for preventing and treating iron-deficiency anemia and secondary infection of young stock |
| 03/04/2009 | CN101375847A Medicament composition with dehydration and diuresis functions |
| 03/04/2009 | CN100465270C Nereides protease, and a separating and purifying method and an application thereof |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100464747C A medicine composition with bailobalide |
| 03/04/2009 | CN100464739C A dispersion tablets used as gynecologic hemostatic and a preparation method thereof |
| 03/03/2009 | US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |